BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health ...